Spinal muscular atrophy: recent advances and future prospects.
about
Drug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIISkeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)Positive regulation of ASK1-mediated c-Jun NH(2)-terminal kinase signaling pathway by the WD-repeat protein Gemin5Effective heritable gene knockdown in zebrafish using synthetic microRNAs.Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophyExpression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA ModelA Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle.Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular AtrophySpinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexesTargeting RNA-splicing for SMA treatment.Perceptions of equine-assisted activities and therapies by parents and children with spinal muscular atrophy.Mechanobiology of embryonic skeletal development: Insights from animal modelsBiophysical stimuli induced by passive movements compensate for lack of skeletal muscle during embryonic skeletogenesis.Survival motor neuron (SMN) protein interacts with transcription corepressor mSin3A.DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse Model of Spinal Muscular Atrophy.Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons.Management of children with spinal muscular atrophy type 1 in Australia.Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.Aquatic therapy for a child with type III spinal muscular atrophy: a case report.Carrier testing in children: exploration of genetic health professionals' practices in Australia.
P2860
Q24200270-5BAB2BB6-EEC2-4C2F-9ECC-AE95E2A627B9Q24200377-554CBB2A-ED16-46D3-BC88-0B29A30DE2BFQ24234414-CD3AA9DB-A93D-4B47-A881-7973DAC8EF1BQ24234523-A2ABFDEB-0D70-4393-AB0F-AC04D3290A61Q24241017-03BB42F9-06C8-4679-9C1B-A005C1635BE3Q24241759-654F6EFA-9E04-4B88-9AAC-8EBB147F1C54Q27312220-C0909B79-72B9-43BF-9776-CADC2226404CQ28304650-130ECAB5-AB38-4799-8D4D-1F2DA4678478Q30654516-BE28E3DB-BB39-46F8-ACEA-5D0542E47D7BQ34673242-69D7745B-550B-423C-881E-FED8175DBB02Q35568525-EF482F62-691A-4619-A119-D3E43305329CQ35647837-0F88F363-D278-4AE8-BDA4-6A5C4C66939AQ36118011-66A8ACD1-A85B-4B92-A5F0-FEE9135F2442Q36199822-2EE34BC8-0CAE-44F2-A7CC-C37753E710C4Q37033848-4B5B27BF-F6EF-4BDA-B8B7-A4C6C6ABA2D8Q37461458-5EA72C5C-3F94-4B35-93AB-7738B84BA4B0Q37673224-B9E2D38B-1160-4AF9-9E0C-8471B8AB99C2Q37791099-36ABB95F-5BEC-4FCB-A509-BB50CE0780E3Q39061796-EE20B538-1AD4-4B48-A2E5-ED1312C92CD3Q40594716-C0968D92-9467-4863-81CA-C6FE80854E98Q41042700-ED139BE6-F676-427D-A676-4696A6F2CD68Q42123203-7245DBF6-9062-47CD-B65D-A8923C2AF72EQ44854592-008AC74C-12F1-4D51-855D-79152D3AD0B7Q47867123-8F6943C1-8289-4785-A5FD-BE5FB6ED150CQ48882843-EF070DF4-2D0C-4FAF-BA1C-553DA6C485E7Q51899232-8E693318-C5FE-4ACC-B260-4538DB74ADCEQ53083998-C80B669B-3066-4A8E-8767-CFC0583FBFC4
P2860
Spinal muscular atrophy: recent advances and future prospects.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Spinal muscular atrophy: recent advances and future prospects.
@ast
Spinal muscular atrophy: recent advances and future prospects.
@en
Spinal muscular atrophy: recent advances and future prospects.
@nl
type
label
Spinal muscular atrophy: recent advances and future prospects.
@ast
Spinal muscular atrophy: recent advances and future prospects.
@en
Spinal muscular atrophy: recent advances and future prospects.
@nl
prefLabel
Spinal muscular atrophy: recent advances and future prospects.
@ast
Spinal muscular atrophy: recent advances and future prospects.
@en
Spinal muscular atrophy: recent advances and future prospects.
@nl
P2860
P356
P1433
P1476
Spinal muscular atrophy: recent advances and future prospects
@en
P2093
Carmen Cifuentes Diaz
Judith Melki
P2860
P356
10.1002/MUS.10110
P577
2002-07-01T00:00:00Z